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UVB exposure of the skin results in increased production
of several cytokines by keratinocytes and infiltration of
inflammatory cells. We hypothesized that UVB may
increase the expression of complement (C) components
and C-regulatory proteins by keratinocytes. In vivo, UVB
may upregulate these proteins by direct effects or via
cytokines released by keratinocytes or infiltrating
inflammatory cells. In vitro, UVB may upregulate these
proteins only directly, because of dilution of released
cytokines in the medium. To test this, we exposed
cultured human keratinocytes to UVB (0–64 J per m2)
and monitored C3 and Factor B release in the medium
by enzyme-linked immunosorbent assay, and surface
expression of decay accelerating factor, membrane cofac-
tor protein, and CD59 by flow cytometry. Keratinocytes
produced small amounts of C3 and Factor B, which
remained unaffected by UVB. UVB (32 J per m2) caused
a transient upregulation of all three C-regulatory proteins.
Decay accelerating factor expression was maximal at 48 h
Human keratinocytes, the major cell type in theepidermis, have been recognized as initiators ofinflammation (Barker et al, 1991). They are immuno-competent cells: they act as accessory cells in T cellresponses (Chu and Morris, 1997) and synthesize a
number of cytokines (Luger and Schwarz, 1990). They also synthesize
complement (C) components C3 (Basset-Seguin et al, 1990) and Factor
B (Yancey et al, 1992). Recently it has been shown that some of
the cytokines produced by keratinocytes and inflammatory cells can
differentially enhance the synthesis of C3 (Terui et al, 1997) and Factor
B (Pasch et al, unpublished work) by keratinocytes. Keratinocytes are
also expected to produce other components of C whose synthesis is
also likely to be regulated by cytokines. Therefore, under inflammatory
conditions of the epidermis, keratinocytes may be considered a local
source of C.
C3 and Factor B produced by keratinocytes are beneficial to the
host in that they participate in the first line of defence against invasion
by foreign cells such as microbes in the skin. These components can
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(1.81 K 0.06-fold increase in mean fluorescence intensity
over nonexposed cells), membrane cofactor protein at
72 h (2.13 K 0.09-fold increase in mean fluorescence
intensity), and CD59 at 120 h (1.96 K 0.09-fold increase
in mean fluorescence intensity), returning to baseline
values within 96, 192, and 192 h, respectively. Exposure
to 64 J per m2 resulted in significant cell death; cells
surviving this dose up to 48 h expressed a higher level of
all the three proteins than those surviving 32 J per m2.
In conclusion, UVB upregulated membrane cofactor
protein, decay accelerating factor, and CD59 on
keratinocytes without affecting the constitutive release of
C3 and Factor B. Thus, UVB can increase the resistance of
keratinocytes against their own C known to be produced
excessively in response to cytokines of inflammatory cells
that infiltrate the skin following UVB exposure. Key words:
complement regulatory molecules/CD59/C3/decay accelerating
factor (DAF)/Factor B/keratinocytes/membrane cofactor protein
(MCP). J Invest Dermatol 111:683–688, 1998
eliminate foreign cells via the alternative pathway of C by generating
the C3/C5-convertases (C3b.Bb)/[(C3b)n.Bb] of the alternative path-
way on them (Asghar, 1997). C5-convertase in the presence of C5
through C9, can cause the assembly of the C5b-9 complex, the
membrane attack complex, on the cell surface that lyzes the foreign cells.
Although C produced by keratinocytes is beneficial in host defence
against foreign cells, it potentially can damage autologous keratinocytes
as well, through the membrane attack complex assembly on them.
Keratinocytes have C-regulatory proteins embedded in their mem-
branes to prevent this damage (Sayama et al, 1991; Dovezenski et al,
1992; Venneker et al, 1994). These include decay accelerating factor
(DAF; CD55), membrane cofactor protein (MCP; CD46), and CD59
(Liszewski et al, 1996). These proteins inhibit different steps of C
activation on cell surfaces. DAF reversibly interferes with the formation
of C3/C5-convertases of both pathways of C and accelerates their
decay (Nicholson-Weller and Wang, 1994). MCP acts as a cofactor
for the C3 cleaving enzyme, Factor I, and interferes irreversibly with
the assembly of C3/C5-convertases of both pathways (Liszewski and
Atkinson, 1992). CD59 is incorporated into the membrane attack
complex during its assembly on the cell membrane and makes the
membrane attack complex noncytolytic (Davies and Lachmann, 1993).
Because DAF, MCP, and CD59 are mostly coexpressed, they act
synergistically to inhibit C activation on autologous cells to protect
them.
Ultraviolet (UV) light exposure of the skin induces dramatic changes
in vivo, among them the release of a large number of cytokines from
keratinocytes, including IL-1, IL-3, IL-4, IL-5, IL-6, IL-8, TNF-α,
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GM-CSF, M-CSF, and MCAF (Schwarz et al, 1994). Some of these
cytokines can attract other cell types, such as monocytes and T cells.
As a result inflammatory cells infiltrate the epidermis after UVB
exposure (Hawk et al, 1988; Di Nuzzo et al, 1996). These cells secrete
cytokines, some of which are not secreted by keratinocytes, e.g., T
cells can secrete IL-2 and IFN-γ (Kelso, 1989; Swain, 1991). Thus,
UVB exposure results in accumulation in the skin of different cytokines,
which have profound effects on cellular immune responses.
From the foregoing and from other studies showing suppression of
delayed hypersensitivity it is clear that UVB exposure exerts important
effects on cellular immune reactions (Granstein, 1990); however, the
effects of UVB exposure on humoral immune system, including the
synthesis of C components, has not yet been studied. We argued that
UVB exposure of the skin may increase synthesis of C components
by keratinocytes either directly or indirectly via some cytokines released
by keratinocytes or by inflammatory cells infiltrating the skin in
response to UVB. If synthesis of components of C is increased after
UVB exposure, increased levels of C can damage keratinocytes.
Therefore, a mechanism(s) must exist to protect keratinocytes from C,
excessively produced by them, in response to UVB. This mechanism
could be the increased expression of C-regulatory proteins on
keratinocyte, either directly by UVB or indirectly via some cytokines
released by keratinocytes or by inflammatory cells infiltrated following
exposure to UVB. We investigated whether direct UVB exposure of
cultured human keratinocytes can increase (i) the constitutive release
of C3 and Factor B and (ii) the surface expression of DAF, MCP,
and CD59.
MATERIALS AND METHODS
Keratinocyte culture Human keratinocytes were isolated by incubation of
foreskin with thermolysin (0.50 mg per ml, Sigma, St. Louis, MO) at 4°C for
16 h and subsequent trypsinization (0.025%) for 5 min at 37°C. Trypsin (Sigma)
was then neutralized by an excess volume of heat inactivated fetal calf serum
(GibcoBRL, Breda, The Netherlands). Cells were separated from debris by
filtering through a nylon mesh, centrifuged, and resuspended in keratinocyte
serum free medium (GibcoBRL) supplemented with penicillin/streptomycin
(100 IU per ml, 100 µg per ml; GibcoBRL). The keratinocytes were plated
onto 100 mm plastic Petri dishes at a density of 400,000 cells per Petri dish
and were incubated at 37°C in humidified, 5% CO2, tissue culture incubator.
Medium was changed every 2–3 d, and at 70% confluence cultures were split
after a 5 min exposure to trypsin (0.025%)/ethylenediamine tetraacetic acid
(EDTA) (1.5 mm) and recultured. For use in experiments, cells were seeded in
6 well tissue culture plates (Costar) at a density of 100,000 cells per well in
2000 µl of medium. Cells in passages 2–5 were used for experiments as soon
as 60%–80% confluence was achieved. Cells in representative wells were
counted by a hemacytometer before the experiment and cells in all wells were
counted after finishing the experiment.
UV exposure and cell viability Subconfluent cultures (60%–80%) of ker-
atinocytes in 6 well culture plates were washed twice with phosphate-buffered
saline (PBS), exposed to increasing doses of UVB (0–64 J per m2), brought to
2 ml of culture medium, and cultured for 48 or 72 h in two sets of experiments.
After incubation, keratinocytes were counted with a hemacytometer and after
propidium iodide staining viability of these cells was determined by flow
cytometer. Cell survival after UVB exposure was expressed as the percentage
of control nonexposed alive cells. Doses that were not lethal to the majority of
the exposed keratinocytes at a given time after exposure (48 or 72 h) were
used in subsequent experiments.
The UVB source consisted of a bank of two Philips TL-12 lamps (Philips,
Eindhoven, The Netherlands). These lamps emit UV in the range of 250–
400 nm, primarily in the UVB region (280–320 nm), with a peak at 315 nm.
The UVB output was 1 J per m2 per second at a target distance of 40 cm and
was monitored by an IL443 radiometer with an SEE 1240 UVB photodetector
(International Light, Newburyport, MA).
Enzyme-linked immunosorbent assay (ELISA) for measurement of C3,
Factor B, and IL-8 The concentrations of C3, Factor B, and IL-8 in culture
supernatants of UVB exposed and nonexposed keratinocytes were estimated
as follows.
For quantitation of C3 a previously described sandwich ELISA (Taktak and
Stenning, 1992) was used with some modifications. Briefly, wells of 96 well
flat-bottom microtiter plates were coated with 0.7 µg polyclonal goat IgG anti-
human C3 (Cappel, Boxtel, The Netherlands) per ml in 100 µl carbonate
buffer (pH 9.6) overnight at 4°C. After thorough washing with Tween-80
(0.05%) (Sigma) in demineralized water the wells were blocked for 1 h at room
temperature with 250 µl PBS containing 2% bovine serum albumin (Sigma)
and 1 mM EDTA. Washing was repeated and wells were incubated with 100 µl
of sample, diluted in the same buffer that was used for blocking. Plates were
incubated for 2 h at 37°C. The wells were then washed and incubated with
100 µl peroxidase labeled goat anti-human C3 IgG (0.05 µg per ml) (Cappel)
for 1 h at 37°C. After washing the wells were incubated with 100 µl
3,39,5,59tetramethylbenzidine (Sigma) in dimethylsulfoxide (Merck,
Hohenbrunn, Germany)-citrate buffer for 10 min. Reaction was stopped with
100 µl H2SO4 (2M). Optical density (OD) was measured at 450 nm. The
detection limit of this ELISA was 1 ng per ml of C3.
Factor B was assayed by a previously described sandwich ELISA (Mitani et al,
1991) with several modifications. Briefly, wells were coated overnight at 4°C
with 3 µg polyclonal goat anti-human Factor B IgG (ATAB, Stillwater, MN)
per ml in carbonate buffer. After thorough washing with PBS/Tween-80
(0.05%), wells were blocked with PBS/milk powder (2%) (Nutricia, Zoetermeer,
The Netherlands) for 1 h at room temperature, and then washed again. Wells
were then incubated for 2 h at 37°C with 100 µl sample, diluted in the same
buffer that was used for blocking, and washed. They were then incubated with
biotinylated goat anti-human Factor B IgG (1.25 µg per ml) for 1 h at 37°C.
After washing, the wells were incubated for another hour at 37°C with
peroxidase conjugated poly streptavidin (1:1000; DAKO, Glostrup, Denmark).
The wells were then repeatedly washed. Incubation of the wells with the
peroxidase substrate, termination of the reaction, and measurement of OD was
carried out as described for C3. The detection limit of this ELISA was
100 pg per ml.
For IL-8 ELISA, wells were coated with 1 µg monoclonal mouse anti-
human IL-8 (Biosource, Breda, The Netherlands) per ml in 100 µl carbonate
buffer (pH 9.6) overnight at 4°C. After thorough washing with Tween-80
(0.05%) in PBS, the wells were blocked for 1 h at 37°C with 200 µl PBS
containing 1% bovine serum albumin. Washing was repeated and wells were
incubated with 100 µl of sample, diluted in the same buffer that was used for
blocking. Plates were incubated for 2 h at 37°C. The wells were then washed
and incubated with 100 µl biotinylated mouse anti-human IL-8 (0.1 µg per ml)
(Biosource) for 1 h at 37°C. After washing, the wells were incubated for
another hour at 37°C with peroxidase conjugated poly streptavidin (1:1000;
DAKO) in PBS/Tween (0.05%)/milkpowder (1%). The wells were then
repeatedly washed. Incubation of the wells with the peroxidase substrate,
termination of the reaction, and measurement of OD was carried out as
described for C3. The detection limit of this ELISA was 5 pg per ml.
Standard curves for C3 and Factor B ELISA were made using human
complement calibrator CA1 (ATAB). Standard curve for IL-8 ELISA was made
using IL-8 Calibrator (Biosource).
Flow cytometry Keratinocytes were detached with the trypsin/EDTA solu-
tion for 3–5 min. Trypsin was inactivated by fetal calf serum and detached cells
were washed and resuspended in fluorescence-activated cell sorter (FACS)
buffer (PBS, 2% fetal calf serum, 0.1% sodium azide). Approximately 105 cells
were incubated with specific monoclonal antibodies to MCP (clone J4–48,
CLB, Amsterdam, The Netherlands), DAF (clone BRIC 110, CLB) or CD59
(1F5) (Okada et al, 1989) or isotype control (Becton Dickinson, San Jose, CA)
for 30 min at 4°C. Cells were washed two times and incubated for 30 min
with fluorescein-conjugated F(ab9)2 fragments of goat anti-mouse IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA). Hereafter, cells were washed
two times with FACS buffer. Propidium iodide (1 mg per ml) (Sigma) was
added to identify dead cells and 20,000 cells were analyzed immediately by
FACSCalibur (Becton Dickinson). Dead cells were excluded.
The detachment of keratinocytes with trypsin (0.025%)/EDTA (1.5 mM) at
37°C for 3–5 min did not cause degradation of any of the three C-regulatory
proteins, as expression of these molecules on cells detached by this procedure
was the same as on those detached with EDTA (2 mM) alone at 42°C for
30 min. The former procedure was selected because it did not cause loss of cell
viability, whereas the latter procedure caused a high degree of loss of cell viability.
Mean fluorescence intensity (MFI) was calculated with WinMDI software.
MFI was corrected for isotype MFI and values of cells not exposed to UVB
were taken as 100%. MFI values obtained from cells exposed to UVB were
presented in terms of the percentage of nonexposed cells.
Statistical analysis Statistical analysis was performed using Wilcoxon signed
rank test to determine significance in FACS experiments and a Student t test
was used for data from ELISA experiments. A p value of less than 0.05 was
considered significant.
RESULTS
Increasing doses of UVB cause progressive loss of cell
viability In order to study the effect of UVB exposure on the
expression of C and C-regulatory proteins by keratinocytes, suitable
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Figure 1. Increasing doses of UVB cause progressive loss of cell viability.
Subconfluent keratinocyte monolayers were exposed to UVB (0–64 J per m2)
and were cultured for 48 h and 72 h. Cells were counted with the hemacytometer
and cell survival was analyzed with the flow cytometer after propidium iodide
staining. Cells living after exposure with each dose are presented as a percentage
of unexposed living cells. Data are averages 6 SD of three experiments.
Figure 2. UVB exposure has no influence on the synthesis of C3 and
Factor B by human keratinocytes. Subconfluent keratinocyte cultures were
exposed to indicated doses of UVB. Supernatants were harvested at 72 h and
concentrations of C3 and Factor B determined by ELISA. IL-8 was included
as a positive control. The figure shows C3, Factor B, and IL-8 protein
concentrations in supernatants of three independent experiments. In each
experiment three wells were exposed to each dose and the contents of each
well were analyzed in quadruplicate. Mean values and SD are shown.
doses of UVB were determined as described in Material and Methods.
Cell survival decreased with increasing doses of UVB (0–64 J per m2)
in both 48 h and 72 h cultures (Fig 1). Exposure of keratinocytes to
64 J per m2 resulted in the death of 45% of the cells in 48 h cultures.
The surviving cells were not able to recuperate. Exposure to 32 J per
m2 resulted in about 10% cell death after 48 h and 50% cell death after
72 h. The cells that survived after 72 h (32 J per m2) were healthy as
assessed by the fact that they were able to proliferate (as seen up to
192 h; data not shown). Therefore, a dose range of 0–32 J per m2 and
a culture time of 72 h were used in most experiments. In some
experiments a dose of 64 J per m2 and a culture time of 48 h were
used to mimic the situation in vivo in which UV exposure results in
keratinocyte death, e.g., sunburn cell formation.
UVB exposure has no influence on the synthesis of C3 and
Factor B by keratinocytes To see if UVB influences the constitutive
production of C3 and Factor B, keratinocytes were exposed to
increasing doses of UVB (4–32 J per m2). Non-exposed cells served
as controls. Both exposed and nonexposed cells were cultured for 72 h
and supernatants were collected. The concentrations of C3, Factor B,
and IL-8 were measured by ELISA in the supernatants.
In supernatants harvested from cultures of nonexposed keratinocytes
C3, Factor B, and IL-8 were found to be present in low concentrations.
In supernatants of cultures of keratinocytes exposed to increasing doses
of UVB, concentrations of C3 and Factor B remained low but
the concentration of IL-8 was significantly increased (Fig 2). IL-8
production was highest at 32 J per m2. The maximal IL-8 level in the
supernatant was 609 pg per ml. To exert biologic activity much higher
concentrations are required (Schroder et al, 1987). These results show
that UVB activates keratinocytes, as could be concluded from the IL-8
production, but does not directly increase the production of C3 and
Factor B.
Figure 3. Cultured human keratinocytes express DAF, MCP, and CD59.
Cultured keratinocytes were washed and 104 cells were analyzed for the
expression of C-regulatory proteins by FACS. Continuous lines show
keratinocyte staining of MCP, DAF, or CD59. Broken lines show staining with
isotype controls. For all parts the data are shown as cell number versus the log
of fluorescence and are representative of three staining experiments each carried
out in triplicate.
Cultured keratinocytes express DAF, MCP, and CD59 Previous
immunohistochemical studies in our laboratory have shown that DAF,
MCP and CD59 were present in situ on several structures of human
skin, including keratinocytes (Venneker et al, 1994). Flow cytometric
analysis of cultured keratinocytes in this study confirmed that all three
proteins were expressed on these cells (Fig 3).
A single dose of UVB causes a prolonged increase in the surface
expression of DAF, MCP, and CD59 When cultured keratinocytes
were exposed to UVB (32 J per m2) and surface expression of the C-
regulatory proteins was analyzed at several time points (0–192 h),
expression of all the three proteins was found to be transiently increased
(Fig 4). DAF expression increased rapidly, reaching its maximum at
48 h after UVB exposure (1.81 6 0.06-fold increase in MFI over
nonexposed cells). Thereafter, DAF expression decreased rapidly,
returning to control values within 96 h. MCP expression increased,
reaching its maximum at 72 h (2.13 6 0.09-fold increase in MFI).
Expression of MCP gradually returned to control values in 192 h.
CD59 expression increased rather slowly, reaching a plateau at 72–
120 h (1.74 6 0.07-fold and 1.96 6 0.09-fold increase in MFI,
respectively). Expression of CD59 returned to almost baseline values
in 192 h.
Increasing doses of UVB cause a dose-dependent increase
in surface expression of C-regulatory proteins Time-response
studies described above showed that with 32 J per m2, surface expression
of DAF was maximal at 48 h of culture after irradiation and surface
expression of MCP and CD59 was maximal at 72 h. Therefore, dose–
response studies with a moderate dose of up to 32 J per m2 were
carried out at 48 h of culture after irradiation for DAF and at 72 h of
culture after irradiation for MCP and CD59. In the case of the
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Figure 4. A single dose of UVB causes
prolonged increase in the surface
expression of DAF, MCP, and CD59.
Subconfluent keratinocyte cultures were
exposed to 32 J per m2 and expression of
DAF, MCP, and CD59 was monitored by
flow cytometer at the indicated time points.
MFI, corrected for isotype control, is shown.
Data represent one of two independent
experiments. In each experiment three wells
were exposed to UVB for each time point
and cells in each well were analyzed in
duplicate. Mean values and SD are shown.
Table I. Effect of increasing doses of UVB on the expression
of MCP, DAF, and CD59 by keratinocytesa
Mean fluorescence intensity (% of untreated cells)
Dose
(J per m2) DAF MCP CD59
0 100.0 100.0 100.0
8 97.4 6 8.0 123.2 6 3.7*** 114.4 6 11.7*
16 102.1 6 1.7 125.8 6 3.3*** 131.1 6 7.3**
32 151.0 6 29.9** 158.6 6 18.0** 183.4 6 18.4***
aSubconfluent cultures were exposed to various doses of UVB. After 48 h (DAF) or
72 h (MCP and CD59) membrane expression of C-regulatory proteins on 20,000 cells
was determined by FACS analysis. MFI values of unexposed keratinocytes were taken as
100%. All values represent mean 6 SD of six experiments; *p , 0.05, **p , 0.01,
***p , 0.001.
expression of DAF, there was no effect of UVB doses up to 16 J per
m2 but the expression was significantly increased with 32 J per m2
(Table I). In the case of MCP and CD59, expression gradually
increased from 8 J per m2 onwards and reached its maximum at
32 J per m2.
A high dose of UVB results in a high surface expression of
DAF, MCP, and CD59 Further studies were aimed at comparing
the effects of moderate (32 J per m2) and high doses of UVB (64 J per
M2) on the expression of all three C-regulatory proteins. The studies
with 32 J per m2 were carried out at time points of maximal expression
of the C-regulatory molecules (48 h for DAF; 72 h for MCP and
CD59; see above) and the studies with 64 J per m2 were carried out
at 48 h of culture because of the low degree of cell survival at 72 h
(see above). The results showed that expression of all three C-regulatory
proteins was higher with 64 J per m2 than with 32 J per m2, although
the difference in expression of MCP did not reach significant levels
(p 5 0.18) (Fig 5).
DISCUSSION
UVB radiation is the mid-range portion (290–320 nm) of the ultraviolet
radiation spectrum (200–400 nm). UVB is present in biologically
significant amounts at the Earth’s surface and exhibits pleomorphic
effects both on the whole organism and on the skin. It penetrates the
stratum basale and reaches the keratinocytes. UVB increases production
of several cytokines by keratinocytes. Some of these cytokines recruit
inflammatory cells and thereby induce inflammation at the site of UVB
exposure of the skin (Hawk et al, 1988; Kondo et al, 1993; Di Nuzzo
et al, 1996). Alteration in production of some cytokines by UVB
induces immunosuppression (Granstein, 1990).
In many inflammatory disorders, like psoriasis, atopic dermatitis,
seborrhoeic dermatitis, and lamellar ichthyosis, C deposits are found
in the epidermis without the presence of autoantibodies (Basset-Seguin
et al, 1993). In some autoimmune diseases, such as pemphigus,
pemphigoid, discoid lupus erythematosus, and photosensitive lupus
erythematosus, C deposits on keratinocytes are seen in lesional skin
but can also be induced in nonlesional skin by UVB exposure (Cram
and Fukuyama, 1972; Morison, 1983). In some diseases of unknown
Figure 5. Increasing doses of UVB cause a progressive increase in
surface expression of DAF, MCP, and CD59. Subconfluent keratinocyte
cultures were exposed to a moderate dose (32 J per m2) and a high dose
(64 J per m2) of UVB. Expression of DAF, MCP, and CD59 was analyzed by
flow cytometer at the time points at which a maximum increase in upregulation
was seen in previous experiments: 48 h for DAF and 72 h for MCP and CD59
with 32 J per m2 and at 48 h for all three proteins at 64 J per m2 (see Fig 4).
Single parameter histograms for DAF, MCP, and CD59 expression are shown.
Thin lines show the expression of DAF, MCP, and CD59 on unexposed
keratinocytes and bold lines show that on UVB-exposed keratinocytes. Broken
lines show the expression obtained with isotype controls. The data are
representative of at least two independent experiments carried out in triplicate.
MFI after exposure to 64 J per m2 was significantly higher for DAF (p , 0.01)
and CD59 (p , 0.001), but not for MCP (p 5 0.18), than after exposure to
32 J per m2.
etiology, such as photoallergy, polymorphous light eruptions, solar
urticaria, solar eczema, and actinic reticuloid, the disease is exacerbated
by light but the role of C remains unknown. In none of these diseases
is the origin of C in the skin known. And, in none of these diseases,
except the aforementioned autoimmune diseases, has the effect of UVB
on the development of C deposits been studied. In spite of these gaps
in knowledge, studies on the effects of UV exposure on the expression
of C and C-regulatory proteins by keratinocytes isolated from normal
individuals and from patients has not been carried out.
We argued that UVB exposure can probably increase the constitutive
production of C components by keratinocytes. In evolutionary terms,
this may be to compensate for local immunosuppression induced by
UVB. We also argued that UVB exposure can increase the surface
expression of C-regulatory proteins on keratinocytes to protect them
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from their own C. We raised the possibility that UVB can upregulate
the synthesis of both C and C-regulatory proteins, either directly
or indirectly via cytokines released by keratinocytes or infiltrated
inflammatory cells.
We observed that keratinocytes constitutively produced small
amounts of C3 and Factor B. This was in agreement with previous
observations (Basset-Seguin et al, 1990; Yancey et al, 1992). Exposure
to UVB caused stimulation of keratinocytes, as evidenced by the
production of IL-8, but did not increase production of C3 and Factor
B (Fig 2). This proved that direct stimulation of keratinocytes by
UVB could not induce an increase in production of C3 and Factor B.
This also raised the question why those C3 and Factor B upregulating
cytokines that are released from keratinocytes upon UVB exposure do
not increase the production of C3 and Factor B in our system. One
of the possible explanations is that they may be released in the medium
in concentrations not high enough to stimulate the keratinocytes. The
concentrations of TNF-α needed to upregulate C3 in our system were
50–1000 U per ml. But the concentrations of TNF-α in culture
medium of UVB-exposed keratinocytes (at 72 h) was found to be very
low (,1 U per ml; data not shown here). The same appears to be
true for IL-8, whose effects on the expression of C3, Factor B, and
C-regulatory proteins are not known. The level of IL-8 in the culture
medium of UVB-exposed keratinocytes was always lower than 610 pg
per ml (Fig 2). Biologically effective IL-8 concentrations vary from 5
to 50 ng per ml (Schroder et al, 1987). These results indicate that
cytokines released from keratinocytes in culture medium after UVB
exposure probably become too diluted to be effective. It remains to
be seen if cytokines released from keratinocytes upon UVB exposure
can upregulate C3 and Factor B in vivo.
DAF, MCP, and CD59 are present on keratinocytes in the human
skin as seen in situ in previous immunohistochemical studies (Dovezen-
ski et al, 1992; Venneker et al, 1994). This study shows surface
expression of DAF, MCP, and CD59 on cultured keratinocytes. The
coexpression of DAF, MCP, and CD59 on human keratinocytes
suggests that these molecules collectively offer a high degree of
protection to keratinocytes against C attack. Indeed, human ker-
atinocytes (Norris et al, 1985) and a keratinocyte-derived squamatous
carcinoma cell line, SCC-12F (Whitlow and Klein, 1997), is remarkably
resistant to complement mediated lysis. In addition, cell death is not a
prominent feature in diseases like pemphigus in which strong C attack
against keratinocytes occurs. Thus, keratinocytes in vivo are strongly
protected against autologous C. Keratinocytes do need strong protection
against C attack under physiologic conditions, because the epidermis
is under a continuous threat of exposure to microbes and other agents
that can activate C and cause bystander C attack on keratinocytes.
This study also shows that the expression of DAF, MCP, and CD59
on keratinocytes is increased for several days by UVB exposure in a
dose-dependent manner. Because these molecules act synergistically,
increases in all three implies that UVB exposure results in a prolonged
and a high degree of protection against autologous C. We did not try
to correlate increased expression with increased protection against C
attack because increased expression of DAF, MCP, and CD59 in
response to UVB exposure could be accompanied by increased or
decreased expression of other C-regulatory proteins, such as comple-
ment receptor 1, C1q receptor, and homologous restriction factor.
Possible changes in expression of these latter C-regulatory proteins
would have made results difficult to interpret. For example, an increase
in the expression of CD59 in the EA.hy926 cell line caused by inducers
of protein kinase C and protein kinase A could not be correlated with
the increase in resistance to C mediated lysis (Meri et al, 1993).
The increased expression of DAF, MCP, and CD59 seen in vitro
could have been due either to a direct effect of UVB on keratinocytes
or to an indirect effect in response to mediators released by keratinocytes.
The latter possibility appears to be less likely because the concentrations
of cytokines released from UVB-exposed keratinocytes into the culture
medium do not appear to be high enough to be able to upregulate C-
regulatory proteins significantly.
If these findings may be extrapolated to the in vivo situation,
keratinocytes in UVB-exposed areas may be better protected against
C mediated lysis than keratinocytes in nonexposed areas. The situation
in vitro, however, may differ from the situation in vivo in which
infiltrating cells may also influence the expression of C-regulatory
proteins through the release of their cytokines.
UVB is known to activate protein kinase C in keratinocytes (Matsui
et al, 1996). Increase in expression of DAF, MCP, and CD59 by
activators of protein kinase C, phorbol myristate acetate, and calcium
ionophore A23187, and an activator of protein kinase A, butyryl-
cAMP, has been shown in our laboratory (data not presented here).
Protein kinase C and protein kinase A signaling may perhaps be
involved in the upregulation of DAF, MCP, and CD59 by UVB.
In conclusion, this study demonstrates that cultured human ker-
atinocytes constitutively release low amounts of C3 and Factor B,
which remain unaffected by UVB. They also express DAF, MCP, and
CD59. Expression of these C-regulatory proteins is increased by UVB.
Because UVB may increase C production in vivo through cytokines of
keratinocytes and infiltrated cells, this increase in C-regulatory proteins
may be important for protecting keratinocytes from becoming bystander
victims of C during UVB-mediated inflammation.
We gratefully thank Dr. Frank Baas for his encouragement throughout the course of
this study.
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